Europe PMCRevisionePancreas
Precision Oncology in Hepatopancreatobiliary Cancer Surgery.
Apri la fonte originale Record tracciabile
01
Abstract
Advances in technology have allowed for the characterization of tumors at the genomic, transcriptomic, and proteomic levels. There are well-established targets for biliary tract cancers, with exciting new targets emerging in pancreatic ductal adenocarcinoma and potential targets in hepatocellular carcinoma. Taken together, these data suggest an important role for molecular profiling for personalizing cancer therapy in advanced disease and need for design of novel neoadjuvant studies to leverage these novel therapeutics perioperatively in the surgical patient.
02
Passaggi indicizzati
I risultati rimandano a queste unità di recupero mantenendo il legame con la pubblicazione.
Questo record non è ancora nell’indice ibrido.